Nevro Corp. (NYSE:NVRO – Get Rating) has been assigned an average recommendation of “Hold” from the twelve research firms that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating on the company. […]
Nevro Corp. (NYSE:NVRO – Get Rating) has been assigned a consensus recommendation of “Hold” from the twelve research firms that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average […]
Shares of Nevro Corp. (NVRO), a medical device company, are losing 17 percent on Tuesday morning trade. Analysts at Truist Financial Co. lowered the stock's target price from $32.
Organizational Change Designed to Drive Strong Growth and Advance Global Commercial Focus
Company Updates Second Quarter 2023 Revenue Guidance
REDWOOD CITY, Calif., June 5, 2023 /PRNewswire/ . | June 5, 2023